Mackay et al. additionally noted that whole-arm 4q deletions were present in some H3.3-G34R/V mutant gliomas, which knocked out FBXW7, an oncogene that regulates the expression of MYC/MYCN by targeting it for proteasomal degradation [2]. Here, MYCN is linked to central nervous system cancer.